Neogenomics shares owned by Group One Trading
Quarter-by-quarter ownership of Neogenomics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Neogenomics
Tip: Access up to 7 years of quarterly data
All positions including Neogenomics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neogenomics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $366k | 25k | 14.75 |
| 2024-06-30 | $491k | 35k | 13.87 |
| 2024-03-31 | $1.9M | 122k | 15.72 |
| 2023-09-30 | $511k | 42k | 12.30 |
| 2023-06-30 | $696k | 43k | 16.07 |
| 2023-03-31 | $486k | 28k | 17.41 |
| 2022-12-31 | $203k | 22k | 9.24 |
| 2022-09-30 | $223k | 26k | 8.61 |
| 2022-06-30 | $232k | 29k | 8.14 |
| 2022-03-31 | $881k | 73k | 12.15 |
| 2021-12-31 | $1.7M | 50k | 34.13 |
| 2021-09-30 | $1.5M | 32k | 48.26 |
| 2021-06-30 | $2.7M | 59k | 45.16 |
| 2021-03-31 | $3.2M | 66k | 48.23 |
| 2020-12-31 | $4.0M | 75k | 53.85 |
| 2020-09-30 | $3.7M | 100k | 36.89 |
| 2020-06-30 | $2.3M | 74k | 30.98 |
| 2020-03-31 | $1.3M | 46k | 27.62 |
| 2019-12-31 | $2.3M | 77k | 29.25 |
| 2019-09-30 | $1.8M | 95k | 19.12 |
| 2019-06-30 | $1.3M | 61k | 21.94 |
| 2019-03-31 | $1.9M | 95k | 20.46 |
| 2018-12-31 | $126k | 10k | 12.60 |
| 2018-06-30 | $69k | 5.3k | 13.02 |
| 2018-03-31 | $503k | 62k | 8.15 |
| 2017-12-31 | $550k | 62k | 8.86 |
| 2017-09-30 | $835k | 75k | 11.13 |
| 2017-06-30 | $705k | 79k | 8.96 |
| 2017-03-31 | $711k | 90k | 7.89 |
| 2016-12-31 | $772k | 90k | 8.57 |
| 2016-09-30 | $675k | 82k | 8.22 |
| 2016-06-30 | $675k | 84k | 8.04 |
| 2016-03-31 | $415k | 62k | 6.74 |
| 2015-12-31 | $610k | 78k | 7.87 |
| 2015-09-30 | $158k | 28k | 5.72 |
| 2015-03-31 | $8.0k | 1.8k | 4.44 |
| 2014-12-31 | $201k | 48k | 4.17 |
| 2014-09-30 | $248k | 48k | 5.21 |
| 2014-03-31 | $1.0k | 400 | 2.50 |
| 2013-12-31 | $2.0k | 600 | 3.33 |
Top funds holding Neogenomics
View all funds holding Neogenomics